Dong-A Socio Holdings Co., Ltd. (KRX:000640)
South Korea · Delayed Price · Currency is KRW 94,500
+3,000 (3.28%)
Last updated: Apr 8, 2026, 2:11 PM KST
Dong-A Socio Holdings Revenue
In the year 2025, Dong-A Socio Holdings had annual revenue of 1.43T KRW with 7.24% growth. Dong-A Socio Holdings had revenue of 371.86B in the quarter ending December 31, 2025, with 7.19% growth.
Revenue
1.43T
Revenue Growth
+7.24%
P/S Ratio
0.42
Revenue / Employee
17.23B
Employees
5,653
Market Cap
606.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.43T | 96.54B | 7.24% |
| Dec 31, 2024 | 1.33T | 201.23B | 17.78% |
| Dec 31, 2023 | 1.13T | 117.14B | 11.54% |
| Dec 31, 2022 | 1.01T | 132.92B | 15.07% |
| Dec 31, 2021 | 881.94B | 98.63B | 12.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daewoong | 2.07T |
| Boryung | 1.02T |
| Huons Global | 847.45B |
| Dong-A ST | 808.78B |
| JW Pharmaceutical | 775.30B |
| Ildong Pharmaceutical | 566.93B |
| Shinpoong Pharmaceutical Co.,Ltd | 234.68B |
| Bukwang Pharmaceutical | 200.71B |